| Serial Number | 79426137 |
| Word Mark | EKARNIA |
| Filing Date | Thursday, February 6, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, February 24, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Advertising services; marketing services; market research; provision of business information; data processing services; compilation of business data; business intelligence services; business and commercial information provided by access to a computer database; business performance measurement, assessment, review and monitoring, namely, business management and consultancy services; provision of supplier, vendor, contractor, agency or supply chain information, including sourcing, tender selection and processing requests for information (RFI), namely, providing business and commercial information; provision of performance feedback about suppliers, vendors, contractors, agencies or businesses in the supply chain; review of suppliers, vendors, contractors or the supply chain through business assessment services, namely, providing independent ratings and reviews of other businesses for commercial purposes; outsourcing services; compilation of business data about suppliers, vendors, contractors and agencies; business consulting services, namely, providing assistance in development of creative ideation; all relating to businesses in the pharmaceutical and biotech industries; consultancy, advisory and information services relating to the above services |
| Goods and Services | Hosting of third party content, photos, text, data, images, web sites and other electronic works, namely, hosting of information, including datasheets, fact sheets, leaflets, brochures, supplier information, all relating to suppliers within the pharmaceutical industry; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing suppliers and service providers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating supplier data for purchasing; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supply chain management; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supplier operational risk management; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing suppliers and service providers; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for generating supplier data for purchasing; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supply chain management; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supplier operational risk management; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing suppliers and service providers; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for generating supplier data for purchasing; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supply chain management; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supplier operational risk management; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Software platform services, namely, platform as a service (PaaS) featuring artificial intelligence software for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; pharmaceutical research and development services; biotech research and development services; consultancy pertaining to pharmacology; providing information relating to scientific research in the fields of biochemistry and biotechnology; preparation of reports in the biotechnology field, namely, information relating to pharmaceutical suppliers and information relating to therapy area, location and size; consultancy, advisory and information services relating to the above services |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Limelight Health Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, June 19, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, June 23, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 23, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 16, 2025 | ASSIGNED TO EXAMINER |
| Friday, July 18, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, July 21, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 22, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, August 26, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, August 26, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, September 12, 2025 | REFUSAL PROCESSED BY IB |
| Monday, February 23, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 23, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 24, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |